Who Owns HBIO?

Harvard Bioscience, Inc. — Institutional Ownership & 13F Holdings

$6.86

+0.00 (+0.00%)

Market Cap

$21.7M

Shares Outstanding

4,471,990

Institutional Holders

91

Total Inst. Value

$14.9M

% of Float Held

QoQ Holder Change

+16

Institutional data as of Q1 2025

New Positions

17

Closed Positions

15

Increased

22

Decreased

35

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1AMH Equity Ltd$1.9M3,387,355
2BlackRock, Inc.$1.6M2,820,462
3Harvey Partners, LLC$1.2M2,187,500
4VANGUARD GROUP INC$1.2M2,138,749
5ROYCE & ASSOCIATES LP$1.0M1,777,894
6Granahan Investment Management, LLC$865K1,527,894
7DIMENSIONAL FUND ADVISORS LP$814K1,437,808
8HEARTLAND ADVISORS INC$627K1,108,578
9ACADIAN ASSET MANAGEMENT LLC$606K1,077,069
10GEODE CAPITAL MANAGEMENT, LLC$522K923,061

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold HBIO?

As of Q1 2025, 91 institutional investors report holding HBIO (Harvard Bioscience, Inc.) in their 13F filings.

Which hedge fund owns the most HBIO?

The largest institutional holder of HBIO is AMH Equity Ltd with $1.9M in shares.

Are institutions buying or selling HBIO?

This quarter, 17 institutions opened new positions in HBIO and 15 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.